Eucabal

Eucabal is a German brand of herbal cold remedies. Most of its products are registered over-the-counter medicines for colds and coughs, sold alongside a thyme bath for babies and children. The range is marketed by Aristo Pharma GmbH of Berlin, is sold only through pharmacies and is aimed mainly at families with young children; its tagline translates as "herbal cold medicine for the whole family". According to its owner, the brand has been in use in herbal cold medicine since 1981 [7].

Eucabal entered the Aristo group in 2009, when its Magdeburg manufacturer, Esparma, joined the pharmaceutical group built by the brothers Thomas and Andreas Strüngmann [8]. It is best known for a eucalyptus and pine-needle chest balm, which drew one of the lowest grades in a 2013 test by the German consumer magazine Öko-Test, and for a bath additive for small children. The brand remains on the market, although its own news output has been quiet since 2022.

Little is documented about how Eucabal began. No founders are named and no founding story has been published. The earliest date attached to the brand comes from Aristo Pharma, which wrote in October 2020 that the "traditional brand" had proven itself in herbal cold medicine since 1981. The wording describes a long market presence rather than a formal founding, and no independent source confirms the year.

The brand's roots run through Magdeburg in eastern Germany. Esparma, the company that made Eucabal before it became part of Aristo, traces its own history to 1875, when Fritz Wilhelm Carl Richter founded a company in the city that produced essential oils. During the 1960s and 1970s the business became the state-owned VEB esparma Magdeburg in the German Democratic Republic (GDR), and after the fall of the Berlin Wall it changed hands several times [12]. The 1875 date belongs to the manufacturer, not to Eucabal. The year 1981 falls within the GDR era, but no documented link shows that Eucabal itself was created at VEB esparma.

The step that shaped the modern brand came in 2009, when Esparma — then the maker of Eucabal and Blemaren — became part of the Strüngmann group. The group had been assembled over the previous decade: the Hilden manufacturer Lindopharm was acquired in 2001, the Berlin family firm Steiner at the end of 2005 and Pharma Wernigerode in 2006, while the generics maker Aristo was founded in 2008 [8].

In 2010 the group's managers decided to bring all products under a single company name, Aristo. The changeover ran gradually over several years, and by August 2013 the trade publication APOTHEKE ADHOC reported that names such as Esparma, Steiner, Lindopharm and Pharma Wernigerode would almost entirely disappear from packaging. The individual product brands were kept, however; Eucabal was listed alongside Kamillan, Imidin, Carvomin, Divalol and Emesan as names that would stay. Esparma itself was later turned into the group's central logistics site at Osterweddingen.

The brand's most visible recent change came in 2020. From August that year the whole range appeared in new packaging, which used warm, saturated colours and illustrations of the medicinal plants behind each product. The children's bath was set apart in shades of pink, a reference to almond blossom. Aristo supported the relaunch with consumer advertising and with material for pharmacies, including patient brochures, posters, window displays and counter stands — one for the cough syrup came with colouring books for children, and one for the bath with rubber ducks. Stock in the old design could continue to be sold [10].

At that point the range consisted of the chest balm (for use from six months), the cough syrup (from one year), the children's bath (with no age limit) and a eucalyptus bath (from seven years). In October 2020 Aristo announced a new addition, the Eucabal Inhalat, a liquid for steam inhalation [7]. That date does not fit every account. A German lifestyle blog writing a year earlier, in October 2019, already described Eucabal Inhalat as available and quoted pharmacists who regarded it as the successor to Sanopin, an inhalation remedy familiar to many households in the former GDR [11]. One possible explanation is that an earlier version of the product existed and was brought back into the relaunched range, but this has not been confirmed.

Eucabal belongs to Aristo Pharma GmbH, based in Berlin. Aristo is part of the pharmaceutical holdings of Thomas and Andreas Strüngmann, the founders of the generics company Hexal [8]. Within the Aristo group the brand sits beside other long-established pharmacy brands, among them Kamillan, Imidin and Sedariston. As of 2013, two further Strüngmann family businesses, Sidroga/Emser and Neuraxpharm, were run separately from the Aristo umbrella.

According to Aristo, Eucabal products are made at Pharma Wernigerode in central Germany, one of the six production sites the group reported in 2020. Pharma Wernigerode had itself joined the group in 2006.

Eucabal presents itself as plant-based cold medicine designed with children in mind. In a 2018 article the company said its cold products had been developed specifically for children's needs and that it deliberately leaves out any substance that might burden or irritate a small child's body. It singles out camphor and menthol, two essential oils often recommended for colds, as unsuitable for children because they can irritate the lining of the nose and airways. Instead, Eucabal says, it relies on pine-needle and eucalyptus oils, which it describes as better suited to children. The brand also notes that its cold products can be prescribed by a paediatrician.

The same 2018 article went further and stated that the products contain no preservatives [6]. That brand-wide claim is contradicted by Eucabal's own later product information: the mandatory text for the cough syrup, dated June 2024, lists methyl- and propyl-4-hydroxybenzoate, two preservatives of the paraben family [4]. The current preservative-free claim is made for the chest balm only.

Aristo frames the brand around a wider shift in pharmacy shopping. Its 2020 announcement said that more and more pharmacy customers were turning to herbal medicines for colds, and that parents of small children in particular wanted remedies that work "naturally and gently". Much of the brand's communication has been aimed at those parents. Its website hosts a long run of articles on colds in children, inhaling, bathing and sleep, several of them written by parenting bloggers.

The current range has five products, all sold in pharmacies. Four are built on a small group of plant ingredients: eucalyptus oil, pine-needle oil, thyme and ribwort plantain.

- Eucabal-Balsam S is a cream containing eucalyptus oil and pine-needle oil, approved to ease the symptoms of colds with thick mucus. It is rubbed onto the back from six months of age and onto the chest from two years. The brand says it is free from camphor, menthol and preservatives. - Eucabal-Hustensaft, a cough syrup with thyme fluid extract and ribwort plantain leaf extract, is registered as a traditional herbal medicinal product. That status rests on the remedy's long-standing use rather than on clinical trials [4]. The syrup also contains alcohol and sugar. - Eucabal Inhalat combines eucalyptus oil and pine-needle oil in a liquid that is added to hot water and breathed in as steam. It is menthol-free and not to be swallowed. - Eucabal Inhalator is a device for steam inhalation. - Eucabal Kinderbad mit Thymian is a bath additive with thyme oil and almond oil. The brand describes it as soothing irritated airways, making children pleasantly tired and caring for delicate skin, and as suitable for babies from their first bath. It is marketed as dermatologically tested, free from foaming agents and suitable for skin prone to atopic dermatitis (eczema).

The eucalyptus bath for children over seven, part of the 2020 range, no longer appears on the brand's product page. No proprietary technologies, patents or research partnerships are documented for the brand.

In early 2021 Eucabal reported that its children's bath had been tested by 44 families for kidsgo, a German magazine for parents. The brand says the bath received an overall grade of 1.3, rated "very good" on the German school-grade scale [5]. This was a consumer panel test rather than a juried award. Separately, the 2019 blog post that linked the Inhalat to Sanopin also warned that many users find its vapour very intense and suggested using fewer drops.

In November 2013 Öko-Test published a test of 20 cold balms, and the results were harsh across the category: only one product was rated "very good", and eight were graded "unsatisfactory" or "deficient". Eucabal-Balsam S, then listed as an Esparma product, was one of two products to receive grade 5, the second-lowest mark [9].

The testers had two main objections. First, they criticised the fact that the balm was intended for use on infants from six months. In their view strongly scented substances pose a danger to small children, because they can trigger a spasm of the larynx and stop breathing. Second, they deducted points because the balm contained more than 100 mg/kg of delta-3-carene, an allergen found in oils from conifer needles. More generally, Öko-Test argued that cold balms should be simply formulated, since blending many essential oils does not improve symptoms and raises the risk of side effects.

The current product page still lists application on the back from six months of age.

Eucabal is an active brand. Its website lists five products, the mandatory medicine text was updated in June 2024, and the site is maintained by Aristo Pharma. Activity on the brand's own channels has slowed, however: the last dated post in its news section appeared in October 2022, and no new product launch has been documented in recent years. The brand's marketing is entirely in German, and no distribution outside Germany is documented.